Pitti Group Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Buy
1,081
+5
+0.5% +$1.08K 0.2% 69
2026
Q1
$234K Buy
1,076
+5
+0.5% +$1.11K 0.19% 71
2025
Q4
$245K Buy
1,071
+46
+4% +$10.5K 0.2% 66
2025
Q3
$237K Buy
+1,025
New +$209K 0.2% 66
2025
Q2
Sell
-1,018
Closed -$213K 79
2025
Q1
$213K Buy
+1,018
New +$198K 0.22% 71

Other funds holding ABBV

Pitti Group Wealth Management's ABBV Position: Q2 2026 in Review

Pitti Group Wealth Management increased its AbbVie (ABBV) stake by 0.46% in Q2 2026, buying an estimated $1.08K and bringing the position to 1,081 shares worth $272K. The position accounts for 0.2% of the portfolio, ranked #69.

Pitti Group Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pitti Group Wealth Management held 1,081 shares of AbbVie worth $272K as of Q2 2026.
  • Pitti Group Wealth Management bought 5 AbbVie shares in Q2 2026, an estimated $1.08K.
  • AbbVie made up 0.2% of Pitti Group Wealth Management's portfolio in Q2 2026, its #69 holding.
  • Pitti Group Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pitti Group Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.